Arteritis clinical trials
The registry lists 135 studies for Arteritis across more than 10 countries. 26 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-08-20.
Status
- Completed
- 64
- Status unknown
- 24
- Recruiting
- 23
- Terminated
- 12
- Withdrawn
- 6
- Not yet recruiting
- 3
Phase
- Phase 2
- 22
- Phase 3
- 15
- Phase 4
- 9
- Phase 1
- 7
- Early Phase 1
- 2
Where
- France
- 33
- United States
- 30
- China
- 21
- Germany
- 15
- United Kingdom
- 13
- Canada
- 12
Who runs them
Shanghai Zhongshan Hospital (7) · University of South Florida (5) · Assistance Publique - Hôpitaux de Paris (4) · Massachusetts General Hospital (4) · University of Oxford (4) · Chinese SLE Treatment And Research Group (4) · University of Pennsylvania (4) · University of Bonn (4)
Studies
Recruiting first, then most recently updated. Showing 50 of 135 — search for more.
- Abatacept for the Treatment of Giant Cell ArteritisRecruitingNCT04474847Phase 33 countries
- National Multicenter Cohort Registry Study of Rapid rEcurrences of Coronary Unexplained In-stent RestenosisRecruitingNCT054379651 country
- Performance of a Fast-track Pathway for Giant Cell Arteritis DiagnosisRecruitingNCT067426711 country
- The Efficacy and Safety of Deucravacitinib in Takayasu's ArteritisNot yet recruitingNCT07013838Phase 41 country
- AYLo - AutoimmunitY and Loss of yRecruitingNCT066960271 country
- Assessing Biomarker in Giant Cell Arteritis and Polymyalgia RheumaticRecruitingNCT064601421 country
- Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory DiseasesRecruitingNCT059043011 country
- Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell ArteritisRecruitingNCT054794481 country
- Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)RecruitingNCT041029301 country
- A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.Not yet recruitingNCT067665521 country
- TocILizumab in aorTitis in GCA (TILT)RecruitingNCT062710181 country
- A Randomized, Controlled, Open-label, Multicenter Clinical Trial Comparing the Efficacy and Safety of a Precision Treatment Regimen Based on Clinical-molecular Phenotypes with a Conventional Treatment Regimen in the Treatment of Patients with Active Takayasu's ArteritisRecruitingNCT06498089Phase 41 country
- Comparison of Tofacitinib and Methotrexate in Takayasu's ArteritisRecruitingNCT05102448Phase 41 country
- Remote Ischemic Conditioning for Cerebral Ischemia in Patients With Takayasu Arteritis (TARIC-1)RecruitingNCT06178419Not applicable1 country
- Visual Involvement in Giant Cell ArteritisRecruitingNCT065007281 country
- Post-therapeutic Imaging Evaluation of Patients With Horton's Disease (Giant Cell Arteritis) (EvHortim)RecruitingNCT060041541 country
- Investigation of the Influence of the Human Microbiome on Giant Cell ArteritisRecruitingNCT062790651 country
- Clonal Hematopoiesis in Giant Cell ArteritisNot yet recruitingNCT06244069
- DANIsh VASculitis Database (DANIVAS)RecruitingNCT059357091 country
- Pediatric Vasculitis InitiativeRecruitingNCT020061347 countries
- Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu ArteritisRecruitingNCT05151848Phase 41 country
- Comparison of Tofacitinib and Prednisolone in the Treatment of Active Takayasu's ArteritisRecruitingNCT05749666Phase 31 country
- A Registry Study on Biomarkers of Takayasu's Arteritis (ARSBTA)RecruitingNCT033729801 country
- A Pilot Study in Severe Patients With Takayasu Arteritis.RecruitingNCT04300686Phase 41 country
- The Registry Study of Takayasu Arteritis in East ChinaRecruitingNCT038931361 country
- China Takayasu Arteritis Registry (CTA Registry)RecruitingNCT029643641 country
- Pain and Music Therapy in Patients Suffering ArteritisCompletedNCT01323504Not applicable1 country
- Comparison of Two Lower Limb Bypass Types : Prosthesis Versus Autologous VeinCompletedNCT00221715Not applicable1 country
- Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical RemissionCompletedNCT05380453Phase 31 country
- Immunomodulatory Effects of PCSK9 InhibitionWithdrawnNCT057201561 country
- Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated VasculitisTerminatedNCT05168475Phase 21 country
- A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK)TerminatedNCT04882072Phase 31 country
- Takayasu Arteritis Clinical Trial in ChinaCompletedNCT02981979Not applicable1 country
- Giant Cell Arteritis - Optimization of DiagnosticsCompletedNCT052489061 country
- Development and Validation of a Fast, Semi-Automated Hybrid Imaging Platform to Assess Coronary Atherosclerotic Plaque Morphology, Endothelial Shear Stress and Arterial Inflammation: A Proof of Principle Study (VALID-PET-CT)CompletedNCT042051101 country
- Evaluation of Platelet Aggregability in Patients with Takayasu's ArteritisActive, not recruitingNCT068077881 country
- Validation of a Diagnostic Algorithm of Giant Cell ArteritisCompletedNCT02703922Not applicable1 country
- Baricitinib for Refractory Takayasu ArteritisCompletedNCT06662721Phase 21 country
- Ustekinumab for the Treatment of Relapse of Refractory Giant Cell ArteritisCompletedNCT03711448Phase 21 country
- Histopathological Analysis of Temporal Artery Biopsy Following Dynamic Full-field Optical Coherence Tomography, a Comparison to Conventional Histopathological Findings in Patients With Suspected Giant Cell Arteritis (DOCTA)CompletedNCT056633331 country
- PET Imaging of Giant Cell and Takayasu ArteritisActive, not recruitingNCT040716911 country
- ICF in Takayasu ArteritisCompletedNCT06289738Not applicable1 country
- Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell ArteritisActive, not recruitingNCT05623592Phase 21 country
- Longitudinal Imaging in Patients With Large Vessel Vasculitis to Predict Further Disease CourseCompletedNCT042048761 country
- Comparative Study of 3 Tocilizumab Products in Normal Healthy VolunteeersCompletedNCT04885829Phase 13 countries
- CXCR4-PET/CT for Diagnosing Giant Cell ArteritisCompletedNCT05604482Not applicable1 country
- Giant Cell Arteritis and Differential Diagnoses Associated With Positive Temporal Artery BiopsyCompletedNCT045542901 country
- KPL-301 for Subjects With Giant Cell ArteritisCompletedNCT03827018Phase 215 countries
- Use of Gallium-68 HA-DOTATATE PET/CT in Giant Cell Arteritis (GCA)CompletedNCT03812302Phase 21 country
- Arterial Inflammation and E-CigarettesCompletedNCT02734888Not applicable1 country